<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref78">
 <mixed-citation publication-type="journal" id="cit78">
  <name>
   <surname>Khanal</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Vausselin</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Barras</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Bande</surname>
   <given-names>O.</given-names>
  </name>; 
  <name>
   <surname>Turcheniuk</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Benazza</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Zaitsev</surname>
   <given-names>V.</given-names>
  </name>; 
  <name>
   <surname>Teodorescu</surname>
   <given-names>C. M.</given-names>
  </name>; 
  <name>
   <surname>Boukherroub</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Siriwardena</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Dubuisson</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Szunerits</surname>
   <given-names>S.</given-names>
  </name>
  <article-title>Phenylboronic-Acid-Modified Nanoparticles: Potential Antiviral Therapeutics</article-title>. 
  <source>ACS Appl. Mater. Interfaces</source>
  <year>2013</year>, 
  <volume>5</volume>, 
  <fpage>12488</fpage>â€“
  <lpage>12498</lpage>. 
  <pub-id pub-id-type="doi">10.1021/am403770q</pub-id>.
  <pub-id pub-id-type="pmid">24180242</pub-id>
 </mixed-citation>
</ref>
